Quick navigation menu :

  1. Go to the content
  2. Go to the main sections menu
  3. Go to the search engine
  4. Go to the help menu
  5. Go to the modules
  6. Go to the shortcuts list

Help menu :

  1. Sanofi Worldwide |
     
  2. US Web Sites |
     
  3. Global Business Websites |
     
  4. Contact us |
  5. Sitemap |
  6. Help
  1. Font size

    Reduce font size Increase font size  
 
 

Perspectives
On Policy

Content :

Perspectives on Policy

Welcome to our Perspectives on Policy where we discuss Sanofi US’s participation in public policy and some of the positions we have taken on key issues. It is part of our efforts to be transparent with our stakeholders.

Sanofi‘s core mission is to discover, develop and deliver innovative healthcare solutions. As part of that mission, we participate in public policy discussions with a focus on issues such as biopharmaceutical innovation, patient access to the medicines and treatments, and reforms that move healthcare from a sickness to a wellness system.

Our participation is led by Corporate Public Affairs, North America. It involves multiple teams within Sanofi as well as external partners such as advocacy and industry organizations.

Our positions address matters at the federal, state and local state levels. We work to understand the interests of patients, payers, providers and policymakers who are also engaged at these levels. In addition, we strive to consider the longer-term interests of our business with respect to intellectual property, research and development, marketing practices, provider education, social responsibility and sustainability, and unmet patient needs.

We express our positions on pending policy as Sanofi or in concert with allies and other stakeholders, all with a goal of reaching practical, consensus-based solutions. In doing so, we maintain compliance with regulatory standards as well as the norms associated with policy development process. Our aim is to improve health outcomes as the primary means of lowering costs.

Voices on Policy Sanofi US, Join the Conversation




Twitter - Follow Us

Last update: December 17, 2014